PatentsGlobal
Genprex Secures Canadian Patent Allowance for REQORSA Gene Therapy Combined with PD-1/PD-L1 Antibodies in Lung Cancer Treatment
Genprex, Inc. announced that the Canadian Intellectual Property Office has issued a Notice of Allowance for a patent protecting the use of its REQORSA gene therapy in combination with PD-1 or PD-L1 antibodies to treat non-small cell and small cell lung cancers. This patent complements existing approvals in multiple co…
Monday, June 22, 2026